BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:The Yale Program in Addiction Medicine is pleased to welcome Y
 ngvild Olsen\, MD\, MPH\, as speaker for the 10th Annual Schottenfeld Lec
 ture on September 8th\, 2026. This event will be held in a hybrid format.
  Please join us in person at the Brady Memorial Laboratory\, or register 
 to attend virtually via Zoom Title: Substance Use Disorder Policy Landsca
 pe in 2026: To Integrated Care and Beyond? Learning Objectives: Describe 
 at least 3 trends that describe the substance use landscape in the United
  States. Characterize the status of 3 addiction-related policy changes or
  regulations that promote integrated care. Identify at least 1 area of op
 portunity for improving outcomes for patients with substance use disorder
 . About Yngvild Olsen\, MD\, MPH Dr. Yngvild Olsen is a National Advisor 
 with Manatt Health. A nationally recognized leader in addiction medicine\
 , public health policy and clinical care integration\, Dr. Olsen provides
  strategic counsel to clients working with substance use disorders (SUDs)
 \, particularly opioid use disorder\, primary care integration and Medica
 id\, as well as state block grants\, Medicaid waivers and behavioral heal
 th integration efforts. With over two decades of experience across clinic
 al\, academic and governmental roles at the local\, state and federal lev
 el—including leadership at REACH Health Services\, Johns Hopkins and the 
 Baltimore Substance Abuse System—Dr. Olsen brings unmatched knowledge\, d
 eep policy insight and a strong national network. She is board-certified 
 in addiction medicine\, trained in general internal medicine and is widel
 y respected for her contributions to advancing addiction treatment and re
 covery nationwide. She has also advised states on the use of Medicaid wai
 vers\, block grant alignment and behavioral health integration strategies
 . Most recently\, Dr. Olsen served as the Director of the Center for Subs
 tance Abuse Treatment at the Substance Abuse and Mental Health Services A
 dministration (SAMHSA)\, where she oversaw $5 billion in grant funding an
 d led national efforts to expand access to care\, strengthen the behavior
 al health workforce and promote evidence-based practices in the treatment
  of SUDs. Dr. Olsen has also held leadership roles at the American Societ
 y of Addiction Medicine (ASAM)\, where she led the association’s policy p
 osition development on a range of substance use-related issues and provid
 ed input on the ASAM Criteria or continuum of care\, which is the most wi
 dely used and comprehensive set of standards and framework for the specia
 lized treatment of patients with addiction and co-occurring conditions. A
 bout the Schottenfeld Lecture The Schottenfeld Lecture is held each Septe
 mber to acknowledge the contributions of our colleague\, Richard Schotten
 feld\, MD\, to the integration of general medicine and addiction treatmen
 t. Dr. Schottenfeld\, an Addiction Psychiatrist and founding Director of 
 the Yale Addiction Psychiatry Residency Training Program\, is an experien
 ced clinician\, teacher and clinical researcher whose work has focused on
  improving the efficacy\, accessibility\, and availability of addiction t
 reatment in the United States and internationally. In the 1980’s and the 
 1990’s\, while at Yale\, Dr. Schottenfeld helped pioneer primary care-bas
 ed models of care for people who inject drugs. He currently serves at the
  Chair of Psychiatry at Howard University College of Medicine. In his rol
 e as a Professor of Psychiatry at Yale\, he was instrumental in supportin
 g and mentoring numerous clinicians and researchers locally and internati
 onally. His work helped lay the foundation for the Yale Program in Addict
 ion Medicine and we are delighted to honor his legacy with the annual Sch
 ottenfeld Lecture. Addiction Medicine Rounds are CME accredited. Each ses
 sion will be assigned 1 AMA PRA Category 1 Credits TM\n\nSpeaker:\nYngvil
 d Olsen\, MD\, MPH\n\nAdmission:\nFree\n\nDetails URL:\nhttps://medicine.
 yale.edu/event/addiction-medicine-grand-rounds-schottenfeld-olsen/\n
DTEND;TZID=America/New_York:20260908T130000
DTSTAMP:20261030T134345Z
DTSTART;TZID=America/New_York:20260908T120000
LOCATION:This session will be held in a hybrid format. Join us in-person i
 n Brady Auditorium (B131)\, or online via Zoom. Register for the virtual 
 session via the link provided.\, URL: https://yalesurvey.ca1.qualtrics.co
 m/jfe/form/SV_cC20XOP6YGxRsRU
SEQUENCE:0
STATUS:Confirmed
SUMMARY:Yale Program in Addiction Medicine's 10th Annual Schottenfeld Lect
 ure
UID:890d7ff1-68bb-429e-bbe1-5f8412fdee54
END:VEVENT
END:VCALENDAR